Krishnaswamy S, Mann K G, Nesheim M E
J Biol Chem. 1986 Jul 5;261(19):8977-84.
The activation of bovine prothrombin by prothrombinase (Factor Xa, Factor Va, synthetic phospholipid vesicles, and calcium ion) was studied in the presence of the fluorescent, reversible thrombin inhibitor dansylarginine-N-(3-ethyl-1,5-pentanediyl) amide (DAPA). Recordings of fluorescence intensity during prothrombin activation exhibited maxima that decreased to stable limiting values. These data suggested the transient appearance of the meizothrombin-DAPA complex, which exhibits fluorescence with 1.5-fold greater intensity than the thrombin-DAPA complex. At substrate concentrations well below Km, progress curves could be fitted by equations describing an ordered, sequential conversion of prothrombin to thrombin through the intermediate meizothrombin via two pseudo-first order steps. The pseudo-first order rate constants for both steps varied linearly with enzyme concentration, indicating that both steps are catalyzed by prothrombinase. The progress of the reaction was also monitored by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and densitometry analyses of aliquots removed at intervals spanning the reaction. These analyses confirmed both the existence of meizothrombin and its time course as predicted from the equations used to analyze fluorescence intensity profiles. Meizothrombin levels peaked at about 0.3 mol/mol initial prothrombin under the conditions typically studied. In addition, prethrombin 2, which is the intermediate expected from cleavages occurring in the order opposite that required to form meizothrombin, was not observed under any of the conditions examined. These data indicate that prothrombin activation catalyzed by the fully assembled prothrombinase complex proceeds via an ordered, sequential reaction with meizothrombin as the sole intermediate.
在荧光可逆凝血酶抑制剂丹磺酰精氨酸 - N -(3 - 乙基 - 1,5 - 戊二胺)酰胺(DAPA)存在的情况下,研究了凝血酶原酶(因子Xa、因子Va、合成磷脂囊泡和钙离子)对牛凝血酶原的激活作用。在凝血酶原激活过程中荧光强度的记录显示出最大值,随后降至稳定的极限值。这些数据表明中间凝血酶 - DAPA复合物短暂出现,其荧光强度比凝血酶 - DAPA复合物高1.5倍。在底物浓度远低于Km时,进程曲线可以用描述凝血酶原通过中间凝血酶依次有序转化为凝血酶的两个伪一级步骤的方程来拟合。两个步骤的伪一级速率常数均随酶浓度线性变化,表明这两个步骤均由凝血酶原酶催化。反应进程还通过十二烷基硫酸钠 - 聚丙烯酰胺凝胶电泳以及对反应过程中不同时间间隔取出的等分试样进行密度分析来监测。这些分析证实了中间凝血酶的存在及其时间进程,正如用于分析荧光强度曲线的方程所预测的那样。在通常研究的条件下,中间凝血酶水平在约0.3摩尔/摩尔初始凝血酶原时达到峰值。此外,在任何检测条件下均未观察到凝血酶原2,它是按照与形成中间凝血酶所需顺序相反的顺序切割产生的中间体。这些数据表明,由完全组装的凝血酶原酶复合物催化的凝血酶原激活通过有序的顺序反应进行,中间凝血酶是唯一的中间体。